52
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Upregulation of STC2 in colorectal cancer and its clinicopathological significance

, , , , , , , & show all
Pages 1249-1258 | Published online: 15 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shasha Li, Qian Huang, Dongliang Li, Lizhi Lv, Yi Li & Zhixian Wu. (2021) The significance of Stanniocalcin 2 in malignancies and mechanisms. Bioengineered 12:1, pages 7276-7285.
Read now

Articles from other publishers (20)

Qiqi Bu, Yangxu Deng, Qing Wang, Rongzhen Deng, Shaofan Hu, Zhigang Pei & Yiguo Zhang. (2023) STC2 is a potential biomarker of hepatocellular carcinoma with its expression being upregulated in Nrf1α-deficient cells, but downregulated in Nrf2-deficient cells. International Journal of Biological Macromolecules 253, pages 127575.
Crossref
Jianxin Zhong, Xi Shen, Junjie Zhou, Heping Yu, Birong Wang, Jianbin Sun, Jing Wang & Feng Liu. (2023) Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer. Frontiers in Oncology 13.
Crossref
Cao Lu, Yang Yang, Li Lingmei, Huang Qiujuan, Guo Qianru, Qi Lisha, Cao Wenfeng, Niu Yun & Zhang peisen. (2022) Identification of hub genes in AR-induced tamoxifen resistance in breast cancer based on weighted gene co-expression network analysis. Breast Cancer Research and Treatment 197:1, pages 71-82.
Crossref
Shuo Qie & Nianli Sang. (2022) Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Yitai Xiao, Guixiong Zhang, Lizhu Wang & Mingzhu Liang. (2022) Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer. Frontiers in Endocrinology 13.
Crossref
Dan Li, Kaifeng Dong, Jing Su, Haitao Xue, Junhai Tian, Yongfeng Wu & Jingtian Wang. (2022) The analysis of tumor-infiltrating immune cell and ceRNA networks in laryngeal squamous cell carcinoma. Medicine 101:31, pages e29555.
Crossref
Qian Chen, Peng Tang, Huishen Huang & Xiaoqiang Qiu. (2022) Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer. Frontiers in Immunology 13.
Crossref
Zhong-Hui Jiang, Xianfeng Shen, Yanhong Wei, Yongji Chen, Hongbo Chai, Lingyun Xia & Weidong Leng. (2022) A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2). Frontiers in Genetics 13.
Crossref
Lihua Yu, Xiaoli Liu, Xinhui Wang, Huiwen Yan, Qing Pu, Yuqing Xie, Juan Du & Zhiyun Yang. (2022) Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy. Frontiers in Cell and Developmental Biology 10.
Crossref
Eun-Jin Yun, Donghwi Kim, Jer-Tsong Hsieh & Seung Tae Baek. (2022) Stanniocalcin 2 drives malignant transformation of human glioblastoma cells by targeting SNAI2 and Matrix Metalloproteinases. Cell Death Discovery 8:1.
Crossref
Shuheng Bai, Ling Chen, Yanli Yan, Rong Li, Yun Zhou, Xuan Wang, Haojing Kang, Zhaode Feng, Guangzu Li, Shuling Zhou, Emmanuel Kwateng Drokow & Juan Ren. (2022) Exploration of Different Hypoxia Patterns and Construction of a Hypoxia-Related Gene Prognostic Index in Colorectal Cancer. Frontiers in Immunology 13.
Crossref
Hui Li, Xiaoping Zhou, Haining Zhang, Jifeng Jiang, Hu Fu & Fang Wang. (2022) Combined Efficacy of CXCL5, STC2, and CHI3L1 in the Diagnosis of Colorectal Cancer. Journal of Oncology 2022, pages 1-10.
Crossref
Zhao Ding, Deshun Yu, Hefeng Li & Yueming Ding. (2021) Prognostic Correlation of Glycolysis-Related Gene Signature in Patients with Laryngeal Cancer. The American Journal of the Medical Sciences 362:2, pages 161-172.
Crossref
Yi He, Haiting Zhou, Wei Wang, Haoran Xu & Hao Cheng. (2021) Construction of a circRNA-miRNA-mRNA Regulatory Network Reveals Potential Mechanism and Treatment Options for Osteosarcoma. Frontiers in Genetics 12.
Crossref
Pankaj Ahluwalia, Ravindra Kolhe & Gagandeep K. Gahlay. (2021) The clinical relevance of gene expression based prognostic signatures in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:2, pages 188513.
Crossref
Fucun Xie, Yi Bai, Xu Yang, Junyu Long, Jinzhu Mao, Jianzhen Lin, Dongxu Wang, Yang Song, Ziyu Xun, Hanchan Huang, Xiaobo Yang, Lei Zhang, Yilei Mao, Xinting Sang & Haitao Zhao. (2020) Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma. International Immunopharmacology 89, pages 107135.
Crossref
Yuchao Liu & Shihua Yin. (2020) A Novel Prognostic Index Based on the Analysis of Glycolysis-Related Genes in Head and Neck Squamous Cell Carcinomas. Journal of Oncology 2020, pages 1-13.
Crossref
Aditya D. Joshi. (2020) New Insights Into Physiological and Pathophysiological Functions of Stanniocalcin 2. Frontiers in Endocrinology 11.
Crossref
Zhenxiang Rong, Yi Rong, Yingru Li, Lei Zhang, Jingwen Peng, Baojia Zou, Nan Zhou & Zihao Pan. (2020) Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients. Frontiers in Oncology 10.
Crossref
Lixia Hu, Yanyan Zha, Fanliang Kong & Yueyin Pan. (2019) Prognostic value of high stanniocalcin 2 expression in solid cancers. Medicine 98:43, pages e17432.
Crossref